Atlas Trials

The Effect of Albumin Supplementation on the Inflammatory and Oxidative Stress Markers in Septic Patients

Clinical trial NCT03950778 · COMPLETED

Trial details

NCT number
NCT03950778
Sponsor
University of Pecs
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Albumin SupplementationAlbumin TherapySepsis
Start date
2023-03-04
Primary completion
2024-03-11
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.